FFR-Guided Complete or Culprit-Only PCI in Patients with Myocardial InfarctionFelix Böhm, Stefan James, Thomas Kellerth et al.|New England Journal of Medicine|2024Cited by 99
Complete Versus Culprit-Only Revascularization in Older Patients With ST-Segment–Elevation Myocardial Infarction: An Individual Patient Meta-AnalysisGianluca Campo, Shamir R. Mehta, Felix Böhm et al.|Circulation|2024Cited by 27
The Full Revasc (Ffr-gUidance for compLete non-cuLprit REVASCularization) Registry-based randomized clinical trialFelix Böhm, Stefan James, Brynjólfur Mogensen et al.|American Heart Journal|2021Cited by 13
Rationale and design of INFINITY-SWEDEHEART: A registry-based randomized clinical trial comparing clinical outcomes of the sirolimus-eluting DynamX bioadaptor to the zotarolimus-eluting Resolute Onyx stentDavid Erlinge, Stefan James, Ole Fröbert et al.|American Heart Journal|2024Cited by 5